Implementation of H.R. 1, Bill to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 (bill formerly known as the Tax Cuts and Jobs Act)
Draft legislation relating to economic activity in Puerto Rico S. 64, Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements
H.R. 1344, Competitive Deals Resulting in Unleashed Generics and Savings Act of 2019 - Provisions related to patent settlements
H.R. 1499, Protecting Consumer Access to Generic Drugs Act of 2019 - Provisions related to patent settlements
H.R. 1503, Orange Book Transparency Act of 2019 - Provisions related to patent listings
H.R. 1506, Fair and Immediate Release of (FAIR) Generic Drugs Act - Provisions related to 180 day exclusivity and patent litigation
H.R. 1520, Purple Book Continuity Act of 2019 - Provisions related to biologics patent listings
S. 659, Biologic Patent Transparency Act - Provisions related to biologic patent disclosures
Biopharmaceutical innovation and patent policy issues
Patent litigation reform issues and issues related to post-grant proceeding at the PTO
Value of intellectual property 
Patent protection H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
H.R. 1046, Medicare Negotiation and Competitive Licensing Act of 2019 - Provisions related to Part D, drug pricing negotiation and march-in rights
S. 474, Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019 - Provisions related to increases in the wholesale acquisition costs of prescription drugs
S. 475, RxCAP Act of 2019
S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019 - Provisions related to transparency of prescription drug pricing and pharmacy benefit managers
Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues
Part D policy issues including non-interference and rebates policy issues
CMS Advanced Notice of Proposed Rulemaking on International Pricing Index Model for Medicare Part B Drugs
CMS Proposed Rulemaking to Require Manufacturers to Disclose Drug Prices in Television Ads
Proposed Rule: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, CMS 4180-P
Proposed Rule: OIG-0936-P Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees Trade Agreements including NAFTA, USMCA and related policy issues H.R. 965, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems
340B drug discount program policy issues
Drug cost and pricing policy issues
Transparency policy issues
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark MMM - Medicare/Medicaid TRD - Trade (domestic/foreign) HCR - Health Issues
14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 10 - Vice President of the U.S. 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 10 - Vice President of the U.S. 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 10 - Vice President of the U.S. 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 10 - Vice President of the U.S. 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 10 - Vice President of the U.S.
ABBVIE, INC.
1399 New York Avenue NW, Suite 600, Washington, DC, 20005, US
DANIEL BACHNER STEPHEN SCANGO COURTNEY PIRON DANIEL BACHNER STEPHEN SCANGO COURTNEY PIRON BINTA BEARD STEPHEN SCANGO DANIEL BACHNER COURTNEY PIRON HAYDEN RHUDY KENNEDY BINTA BEARD DANIEL BACHNER COURTNEY PIRON STEPHEN SCANGO STEPHEN SCANGO DANIEL BACHNER COURTNEY PIRON HAYDEN RHUDY KENNEDY BINTA BEARD